Active Ingredient: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Proprietary Name: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; SUBLINGUAL
Strength: EQ 2MG BASE;EQ 0.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A214930
Product Number: 001
Approval Date: Jun 15, 2021
Applicant Holder Full Name: ALKEM LABORATORIES LTD
Marketing Status:
Prescription
Patent and Exclusivity Information